SCHEMBL19620504

SCHEMBL19620504

NC1=C(OSCc2ccccc2)C(=O)C(c2ccnc3ccccc23)O1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.43
MAPT P10636 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
PTK2B Q14289 1/20 0.43
MAOB P27338 5/20 0.36
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
CASP1 P29466 1/20 0.34
BRCA1 P38398 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620552 0.82 GSK3B (0.39) MAPTMAOBALDH1A1KDM4ECYP1A2
SCHEMBL29852012 0.80 MAPT (0.43) TP53MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL19620635 0.80 TP53 (0.43) TP53MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL15627554 0.80 MAPT (0.43) TP53MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL19620550 0.79 KMT2A (0.39) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL19620603 0.78 POLB (0.50) TP53MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL19620533 0.78 MAPT (0.42) TP53MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL19620625 0.78 CYP1A2 (0.34) MAPTMAOBALDH1A1KDM4ECYP1A2
SCHEMBL19620528 0.78 DPP4 (0.36) MAPTSMN1; SMN2KDM4ECYP1A2CYP3A4
SCHEMBL19620456 0.77 TOP2A (0.36) MAPTRAB9AMAOBKDM4EELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345596-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2021-01-20 EP disclosed
EP-3345596-A2 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2018-07-11 EP disclosed
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed